Trial Comparing Complication Rates Associated With Robot-assisted Thyroidectomy to External Thyroidectomy

Randomized Trial Comparing Complication Rates Associated With Robot-assisted Thyroidectomy to External Thyroidectomy

The main objective is to compare 12 month complication rates between a new surgical method for thyroidectomy (robot-assisted endoscopic thyroidectomy via a sub-clavical approach) and open thyroidectomy.

Study Overview

Study Type

Interventional

Enrollment (Actual)

5

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Gard
      • Nîmes Cedex 09, Gard, France, 30029
        • CHU de Nimes - Hopital Universitaire Caremeau

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 83 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • The patient must have given his/her informed and signed consent
  • The patient must be insured or beneficiary of a health insurance plan
  • The patient is available for 12 months of follow-up
  • The patient is a candidate for total thyroidectomy because of a nodular pathology, a diffuse goiter, thyroiditis, or Basedow's disease
  • Patient has calcitoninemia < 9 ng/pl
  • Patient has normal calcemia
  • Patient has PTH level between 5 ng/l and 75 ng/l
  • The subject has a normal laryngeal mobility

Exclusion Criteria:

  • The patient is participating in another study
  • The patient is in an exclusion period determined by a previous study
  • The patient is under judicial protection, under tutorship or curatorship
  • The patient refuses to sign the consent
  • It is impossible to correctly inform the patient
  • The patient is pregnant
  • The patient is breastfeeding
  • The patient is not available for 12 months of follow-up
  • Subject has a preoperative diagnosis of cancer on fine needle aspiration biopsy of the thyroid or cervical lymph node
  • Lymph node metastasis strongly suspected clinically and/or sonographically
  • The subject has an extension of substernal thyroid (diving goiter)
  • Family history of medullary thyroid cancer
  • The subject has a history of neck surgery
  • Contraindication for general anesthesia

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Robot arm
Patients in this arm will have a thyroidectomy performed using a robot-assisted endoscopic technique.
Patients will have a thyroidectomy via a robot-assisted (da Vinci robot) endoscopic (subclavical entry)surgical technique.
Active Comparator: Open surgery
Patients in this arm will have a thyroidectomy using an open surgical technique.
Patients will have a conventional (non-endoscopic) thyroidectomy using an open surgical technique

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Presence/absence of complications (composite score)
Time Frame: 12 months
The per or post-operative occurrence of at least one of the following: postoperative hemorrhage requiring reintervention; cervical infection requiring antibiotics and/or surgical intervention; transient or persistent laryngeal paralysis; transient or persistent hypoparathyroidy (calcemia < 1.9 µmol/l). Transiient means < than and persistent means >= 12 months.
12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incision size (mm)
Time Frame: 12 months
Length of incision in the open group, and sum of incision lengths in the robot group.
12 months
Patient satisfaction score
Time Frame: 12 months
Patient satisfaction as regards the incision scar measured using a visual analog scale from 0.0 to 10.0.
12 months
Presence/absence of conversion to open technique
Time Frame: 1 day
For patients in the robot arm: presence/absence of conversion to open technique.
1 day
Operating room prep time (min)
Time Frame: 1 day
Time in minutes necessary to prep the operating room
1 day
Presence/absence of per-operative complications
Time Frame: 1 day
Presence/absence of per-operative complications
1 day
Hospital stay (d)
Time Frame: 7 to 15 days post-op
Length of hospitalization in days required after thyroidectomy
7 to 15 days post-op
Change in thyroglobulinemia (ng/l)
Time Frame: 12 months
Thyroglobulinemia at 12 months - Thryoglobulinemia as baseline
12 months
Change in calcemia (mg/l)
Time Frame: Day 1
Calcemia on Day 1 - Calcemia at inclusion
Day 1
Change in calcemia (mg/l)
Time Frame: Day 7 to 15
Calcemia at the control visit (days 7 to 15) - Calcemia at inclusion
Day 7 to 15
Change in calcemia (mg/l)
Time Frame: 12 months
Calcemia at 12 months - Calcemia at inclusion
12 months
Change in phosphoremia (mg/l)
Time Frame: Day 1
Phosphoremia at 1 day postop - Phosphoremia at inclusion
Day 1
Change in phosphoremia (mg/l)
Time Frame: Days 7 to 15
Phosphoremia at control visit (days 7 to 15) - Phosphoremia at inclusion
Days 7 to 15
Change in phosphoremia (mg/l)
Time Frame: 12 months
Phosphoremia at 12 months - Phosphoremia at inclusion
12 months
Change in parathormonemia (ng/l)
Time Frame: Day 1
Parathormonemia on Day 1 post-op - parathormonemia at inclusion
Day 1
Change in parathormonemia (ng/l)
Time Frame: Days 7 to 15
Parathormonemia at control visit (days 7 to 15) - parathormonemia at inclusion
Days 7 to 15
Change in parathormonemia (ng/l)
Time Frame: 12 months
Parathormonemia at 12 months - parathormonemia at inclusion
12 months
Visual Analog Pain Score
Time Frame: Day 1
Visual Analog Scale for pain (0.0 to 10.0)
Day 1
Visual Analog Pain Score
Time Frame: Days 7 to 15
Visual Analog Scale for pain (0.0 to 10.0)
Days 7 to 15
Visual Analog Pain Score
Time Frame: 12 months
Visual Analog Scale for pain (0.0 to 10.0)
12 months
Direct medical costs (€)
Time Frame: 12 months
12 months
Indirect medical costs (€)
Time Frame: 12 months
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2011

Primary Completion (Actual)

September 1, 2013

Study Completion (Actual)

September 1, 2013

Study Registration Dates

First Submitted

March 22, 2011

First Submitted That Met QC Criteria

March 22, 2011

First Posted (Estimate)

March 23, 2011

Study Record Updates

Last Update Posted (Estimate)

March 25, 2015

Last Update Submitted That Met QC Criteria

March 24, 2015

Last Verified

March 1, 2015

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Graves Disease

Clinical Trials on Robot-assisted thyroidectomy

3
Subscribe